Anti-tumorigenic components of a sea weed, Eeteromorpha clathrata

Hanjun Tang1, Mamiko Inoue, Yuki Uzawa

  • 1Department of Applied Life Chemistry, Graduate School of Agriculture, Kinki University, Nara 631-0052, Japan. t-hanjun@nara.kindai.ac.jp

Insights

Seaweed extracts were tested for anti-cancer properties. Ethanol extracts from Sujiaonori seaweed showed selective cytotoxicity against cancer cells, indicating potential anti-tumorigenic compounds.

Area of Science:

  • Marine Natural Products Chemistry
  • Cancer Biology
  • Pharmacology

Background:

  • Seaweed compounds are increasingly investigated for medicinal properties.
  • Selective cytotoxicity is a key characteristic for anti-cancer drug development.
  • Understanding the anti-tumorigenic potential of marine algae is crucial.

Purpose of the Study:

  • To evaluate the anti-tumorigenic action of compounds from various seaweeds.
  • To identify seaweed extracts with selective cytotoxicity against transformed cells.
  • To characterize the active components responsible for anti-cancer effects.

Main Methods:

  • Cultured mouse 3T3 cells (SV-T2 and normal counterpart) were treated with seaweed extracts.
  • Cell viability was assessed 24 hours post-treatment using a 96-well microplate assay.
  • Active fractions were isolated using gel permeation chromatography (Sephadex G-50).

Main Results:

  • Ethanol extracts from Sujiaonori seaweed demonstrated selective cytotoxicity.
  • Gel permeation chromatography yielded two fractions with anti-cancer activity: high molecular weight (proteinaceous) and low molecular weight (~500 Dalton).
  • High molecular weight fractions showed absorbance at 280 nm, indicating protein content.

Conclusions:

  • Sujiaonori seaweed contains compounds with selective anti-cancer activity.
  • Both proteinaceous and low-molecular-weight compounds contribute to the anti-tumorigenic effects.
  • Further research into these fractions may lead to novel cancer therapeutics.